Package 51407-982-01

{"route": ["ORAL"], "spl_id": "362630bd-45d0-43b4-e063-6394a90af71e", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["36262a4c-33f1-40a5-e063-6394a90ad36a"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-982-01)", "package_ndc": "51407-982-01", "marketing_start_date": "20250507"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-982-10)", "package_ndc": "51407-982-10", "marketing_start_date": "20250507"}], "brand_name": "Phenytoin Sodium", "product_id": "51407-982_362630bd-45d0-43b4-e063-6394a90af71e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51407-982", "generic_name": "Phenytoin Sodium", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20060905", "listing_expiration_date": "20261231"}